Local Sodium Tanshinone IIA Sulfonate Attenuates Periodontal Bone Loss by Modulating Inflammatory, Immune and Osteoclastogenic Signalling
Journal of Clinical Periodontology · 2026
DOI: 10.1111/jcpe.70159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Periodontology, 2026. Verfasst von Rafael Scaf de Molon und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Surgery, School of Dentistry, São Paulo State University (UNESP), Araçatuba, São Paulo, Brazil. Hauptthemen laut MEDLINE: Alveolar Bone Loss, Signal Transduction, Osteoclasts, Periodontitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Aim
To investigate whether local administration of sodium tanshinone IIA sulfonate (STS) modulates periodontal inflammation, alveolar bone loss, immune response and bone remodelling–related signalling pathways in a ligature‐induced murine model of periodontitis. Materials and Methods Sixty C57BL/6J male mice were randomly assigned to four groups: control group (C), periodontitis (P), low‐dose (1 mg/kg) tanshinone (STS1) and high‐dose (5 mg/kg) tanshinone treatment (STS5). Experimental periodontitis was induced by bilateral placement of ligatures around the first maxillary molars in the P, STS1 and STS5 groups. STS or vehicle was administered locally to the gingival tissues 2 days before disease induction and continued until the end of the experiment.
Results
STS significantly attenuated periodontal bone loss, preserved bone microarchitecture, reduced inflammatory infiltrate and maintained collagen organisation. Mechanistically, STS suppressed RANKL‐dependent osteoclastogenesis by down‐regulating RANKL, CTSK, MMP‐9, OSCAR and NFATc1 mRNA expression while restoring the RANKL/OPG balance, thereby limiting osteoclast differentiation and activity. In parallel, STS attenuated inflammatory signalling by inhibiting NF‐κB pathway activation, as reflected by reduced NF‐κB protein levels, stabilisation of its inhibitory regulator IκBα as well as suppression of IL‐6, TNF‐α and TGF‐β gene expression, followed by a trend towards reduced IFN‐γ gene levels. STS further modulated macrophage polarisation by reducing M1‐like macrophages, as shown by decreased F4/80 + CD80 + signal, while CD206 immunoreactivity increased. At the protein level, STS reduced TRAP, CTSK and NFATc1 expression while restoring RUNX2.
Conclusion
STS effectively suppresses periodontal inflammation and alveolar bone destruction by modulating inflammatory signalling and attenuating M1‐like macrophage polarisation, inhibiting osteoclastogenesis and partially restoring osteogenic pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic and Surgery, School of Dentistry, São Paulo State University (UNESP), Araçatuba, São Paulo, Brazil.
- Department of Morphology, Genetics, Orthodontics and Pediatric Dentistry, School of Dentistry, São Paulo State University-UNESP, Araraquara, São Paulo, Brazil.
- Department of Diagnosis and Surgery, School of Dentistry, São Paulo State University-UNESP, Araraquara, São Paulo, Brazil.
- Department of Basic Sciences, School of Dentistry, São Paulo State University (UNESP), Araçatuba, São Paulo, Brazil.
- Department of Dental Materials and Prosthodontics, School of Dentistry, São Paulo State University-UNESP, Araraquara, São Paulo, Brazil.
- Division of Diagnostic and Surgical Sciences, UCLA School of Dentistry, Los Angeles, California, USA.
ORCID-Profile: Rafael Scaf de Molon, Raquel Mantuaneli Scarel-Caminaga, François Isnaldo Dias Caldeira, Edilson Ervolino, Erica Dorigatti de Avila, Leticia Helena Theodoro, Joni Augusto Cirelli, Sotirios Tetradis
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
de Molon, R. S., Scarel-Caminaga, R. M., Caldeira, F. I. D., Ervolino, E., de Avila, E. D., Barbugli, P. A., Oliveira, G. E., Franco-Moura, J. P., Theodoro, L. H., Cirelli, J. A., Tetradis, S., & Kantarci, A. (2026). Local Sodium Tanshinone IIA Sulfonate Attenuates Periodontal Bone Loss by Modulating Inflammatory, Immune and Osteoclastogenic Signalling. Journal of Clinical Periodontology. https://doi.org/10.1111/jcpe.70159
Vancouver
de Molon RS, Scarel-Caminaga RM, Caldeira FID, Ervolino E, de Avila ED, Barbugli PA, et al. Local Sodium Tanshinone IIA Sulfonate Attenuates Periodontal Bone Loss by Modulating Inflammatory, Immune and Osteoclastogenic Signalling. Journal of Clinical Periodontology. 2026. doi:10.1111/jcpe.70159
BibTeX
@article{deMolon2026,
author = {de Molon, Rafael Scaf and Scarel-Caminaga, Raquel Mantuaneli and Caldeira, François Isnaldo Dias and Ervolino, Edilson and de Avila, Erica Dorigatti and Barbugli, Paula Aboud and Oliveira, Gabriela Ezequiel and Franco-Moura, Joao Pedro and Theodoro, Leticia Helena and Cirelli, Joni Augusto and Tetradis, Sotirios and Kantarci, Alpdogan},
title = {Local Sodium Tanshinone IIA Sulfonate Attenuates Periodontal Bone Loss by Modulating Inflammatory, Immune and Osteoclastogenic Signalling},
journal = {Journal of Clinical Periodontology},
year = {2026},
doi = {10.1111/jcpe.70159}
}
EUVIMED